Blawg Search - Law Blogs, Lawyer Blogs, Legal Blogs Directory & Search Engine

... recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Daiichi Sankyo Co., Ltd. et al. v. Apotex, Inc. et al. 1:09-cv-03997; filed July 2, 2009 in the Northern District of Illinois Daiichi Sankyo Co. Ltd. et al. v. Apotex Inc. et al. 1:09-cv-00470; filed June 26, 2009 in the District Court of Delaware • Plaintiffs: Daiichi Sankyo Co. Ltd.; Daiichi Sankyo, Inc. • Defendants: Apotex Inc.; Apotex Corp. The complaints in these cases ...

In Daiichi Sankyo Co., LTD v. Apotex, Inc., et al. (reissued as a precedential opinion on Septmembr 12, 2006), the Federal Circuit looked to the experience of the inventors to hold that prior art publication directed at ... invention, Inventor Sato was a university professor specializing in otorhinolaryngology; Inventor Handa was a clinical development department manager at Daiichi, where he was involved with new drug development and clinical trials; and Inventor Kitahara was a research scientist at ...

... readers. So, instead of cutting the cases into tasty morsels, we offer these savory chunks: Daiichi Sankyo Co., Ltd. v. Apotex, Inc. , No 06-1564 (Fed. Cir. Sept. 12, 2007) -- ... bacterial ear infections fails the pre-KSR test for obviousness. ACCO Brands, Inc. v. ABA Locks Manufacturer Co., Ltd., No. 06-1570 (Fed. Cir. Sept. 12, 2007) -- Evidence of direct infringement of a patent on "Computer Physical Security Device" failed to support the jury's verdict of infringement by inducement. Arminak & ...

Bloomberg reports on 31 July: Daiichi Sankyo Co.'s longer-acting version of GlaxoSmithKline Plc's flu drug, Relenza, was as effective as a course of Tamiflu, a patient study found. The safety and efficacy of a ... indistinguishable'' from a twice-a- day dose of Roche Holding AG's Tamiflu taken for five days, said Melbourne-based Biota Holdings Ltd., which is developing the drug with Japan's Daiichi Sankyo. The study, involving ``several hundred'' patients with seasonal flu, was the second of three ...

... logged $12.4 billion in revenue last year, $7.7 billion of it in the U.S. Ranbaxy Laboratories Ltd., India's biggest drugmaker and majority owned by Japan's Daiichi Sankyo Co., settled a lawsuit filed by Pfizer and plans to enter the market in November 2011. Pfizer already is suing Apotex Inc. and Teva Pharmaceutical Industries Ltd. to prevent them from selling copies of the medicine before then. Read the full article here.

... Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada ... Dexcel from marketing formula containing Cyclosporins: Novartis AG v Dexcel-Pharma Ltd: (IPKat), Eloxatin (Oxaliplatin) - South Korean court dismisses Sanofi-Aventis' patent ... Court rules on trade mark use and parallel imports in Honda Motor Co Ltd v Derek James Neesam: (International Law Office), Strategic Advisory ...

... WIPO symposium to discuss life sciences multilateral environmental agreements: (Daily Dose of IP), Daiichi Sankyo and Ranbaxy confirm deal is binding and final, allay market rumour ... trade mark infringement proceedings after Customs seizure: Jamella Australia Pty Ltd v MacKinnon: (Australia & New Zealand Intellectual Property Law) Belgium ... in patent infringement case, relies on patentee's advice on counsel: Fisher Tools Co, Inc v Gillet Outillage: (IP Spotlight), Google - Google accused of ad ...

... : (IP Law360), Pharma & Biotech - Products Azor (Amlodipine/Olmesartan) - US: Daiichi Sankyo files patent infringement suit against Mylan unit, Matrix Lab's ... UK relaxes approach to Swiss claims: Actavis UK Limited v Merck & Co Inc: (Managing Intellectual Property), Protonix (Pantoprazole) - US: Would-be class action ... Charlesworth: (IPRoo), Federal tribunals and summary disposal: Memcor Australia Pty Ltd v Zenon Environmental Inc: (IPRoo), Extension of time to file evidence in opposition: ...